Kolexia
Andre Michel
Pneumologie
Centre hospitalier de Cornouaille
Quimper, France
50 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules COVID-19 Embolie Pneumothorax Embolie pulmonaire Hypoxie Infections à coronavirus

Industries

MSD
5 collaboration(s)
Dernière en 2023
AstraZeneca
5 collaboration(s)
Dernière en 2023
Pfizer
2 collaboration(s)
Dernière en 2023
Ipsen
1 collaboration(s)
Dernière en 2023

Dernières activités

1035P A phase II trial of nivolumab and denosumab association as second-line treatment for stage IV non-small-cell lung cancer (NSCLC) with bone metastases: DENIVOS study (GFPC 06-2017)
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
Molecular profile of non-small cell lung cancer in reunion Island.
Respiratory medicine and research   27 juin 2022
High Prevalence of Nontuberculous Mycobacteria in Cystic Fibrosis Patients in Tropical French Reunion Island.
The Pediatric infectious disease journal   24 septembre 2021
Co-infection in patients with hypoxemic pneumonia due to COVID-19 in Reunion Island.
Medicine   05 février 2021
Pulmonary embolism in a returning traveller with COVID-19 pneumonia.
Journal of travel medicine   02 septembre 2020
A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: Results of a retrospective observational study in the French overseas department of Réunion Island.
Journal of global antimicrobial resistance   20 août 2020
Co-infection of dengue and COVID-19: A case report.
PLoS neglected tropical diseases   03 août 2020
Detection of Pulmonary Embolism in Returning Travelers with Hypoxemic Pneumonia due to COVID-19 in Reunion Island.
The American journal of tropical medicine and hygiene   01 juillet 2020
Real-Life Efficacy of Osimertinib in Pretreated Octogenarian Patients with T790M-Mutated Advanced Non-small Cell Lung Cancer.
Targeted oncology   02 mars 2020
Management and outcomes of non-small cell lung cancer patients with rapid progression under second-or-more-line immune checkpoint inhibitors: ERORECI study (GFPC 2016-04).
Cancer medicine   20 novembre 2019